Clinical development built for mid-size pharma
Scale without the complexity
ICON delivers flexible, integrated solutions designed for mid‑size pharma companies with growing pipelines, lean teams and global ambition.
Mid-size pharmaceutical sponsors sit at a critical inflection point. Pipelines are expanding fast, expectations are rising, and internal teams are under pressure to deliver predictable outcomes without the full scale of the infrastructure of larger pharma sponsors.
ICON partners with mid-size organisations to provide the capacity, expertise and continuity needed to move faster with confidence. We combine the reach of a global CRO with high-touch delivery models that reduce operational burden, strengthen governance and scale with your ambition, from first study to global programmes.
One accountable outsourcing partner, fewer moving parts
Fragmented outsourcing often adds cost, complexity and delivery risk. ICON offers an integrated, end‑to‑end clinical development approach that consolidates vendors, simplifies oversight and creates a single point of accountability across phases and functions.
Built to move at your speed
ICON’s agile operating models compress timelines where it matters most, at study start‑up, site activation and early recruitment, without creating complex governance overhead.
Support that scales as you grow
From tactical support to full‑service delivery, ICON’s flexible FSP, hybrid and full‑service models allow you to scale quickly without overbuilding internal teams or losing control.
.jpeg?crop=yes&w=235&h=235&itok=ajg38Efs "blended_solutions_woman_looking_at_laptop"){kind=icon}
High‑touch partnership within a global CRO
Dedicated, therapeutically aligned teams ensure continuity, senior oversight and relevance, addressing the common concern that large CROs are “too big” for mid‑size sponsors.
Proven results, without added organisational burden
For lean organisations, performance improvements must come without additional layers of oversight or internal strain. ICON’s results reflect delivery models built specifically to reduce management effort while improving speed, quality and predictability as programmes scale.
- 53% reduction in median site identification time and 50% faster site activation
- Up to 25% reduction in operational costs through regional delivery hubs
- 99% pharmacovigilance compliance across 100+ countries
- Over 90 long‑term partnerships using flexible delivery models